Navigation Links
Prescribing Off Label Drugs for Children may Be Hazardous

A recent pediatric study finds that nearly four out of five hospitalized children receive medications that have been tested and approved only for adults//. The authors fear that treating children with off-label medications can have adverse outcomes.

"We measured the magnitude of off-label use of drugs in children," said study leader Samir S. Shah, M.D., a pediatrician specializing in infectious diseases at The Children’s Hospital of Philadelphia. "Given the nature of the available data, we could not evaluate safety and effectiveness of those medications, although those are important concerns. However, only a small number of drugs have been formally tested in children."

Once the U.S. Food and Drug Administration (FDA) approves a drug for any indicated use, physicians may legally prescribe the drug for different conditions and for patients in other age groups. This study measured off-label use only as defined by age, not by indicated conditions.

"With nearly 80 percent of children receiving off-label medications during hospitalizations, we need to focus our attention on the process by which medications are approved for pediatrics," said senior author Anthony D. Slonim, M.D., Dr.P.H., Executive Director of the Center for Clinical Effectiveness at Children’s National Medical Center. "It is imperative that we thoroughly review this process to ensure that children are being treated with the safest, most effective therapies."

Researchers in the Pediatric Health Information Systems Research Group, representing various medical centers, analyzed patient records from 31 major U.S. children’s hospitals for the entire year of 2004. At least one drug was used off-label in 79 percent of the more than 355,000 children requiring hospitalization. Off-label use accounted for $270 million, some 40 percent, of the total dollars spent on children’s medication in the study, which appears in the March issue of the Archives of Pediatrics and A
'"/>




Page: 1 2 3

Related medicine news :

1. Physicians Consider Self-Prescribing Ethical
2. The Dangers Of Prescribing Antibiotics
3. Doctors Do Not Excise Sufficient Caution While Prescribing High-Risk Drugs
4. GPs In Wales Support Minister on Prescribing Issue
5. Many Medical Students Unprepared for Skilled Prescribing
6. Physician Communication Spotty When Prescribing Medications
7. Free Drug Samples Influence Prescribing, Say One in Three Doctors
8. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
9. Impotence Drugs Ordered by FDA to have Label Change
10. The Dangers Of Vitamin A To Pregnant Women To Be Included On Label
11. Identifying What Consumers Look For On Food Stuff Labels
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Prescribing Off Label Drugs for Children may Hazardous

(Date:7/24/2014)... Mass. (PRWEB) July 24, 2014 Dr. ... Beth Israel Deaconess Medical Center in Boston, is the ... . Dr. Oettgen brings his considerable experience in the ... EBSCO Health . , Dr. Oettgen received his ... Medicine and completed his residency at Tufts New England ...
(Date:7/24/2014)... July 24, 2014 The first-ever successful ... a patient’s blood has been achieved by NFCR-supported scientist ... General Hospital. This is an important milestone on the ... selecting the best treatment for each patient. , ... “They often acquire new genetic features that make them ...
(Date:7/24/2014)... LSE Health and the European Heart Academy (EHA) ... pleased to announce the launch of a new, ... field of cardiovascular sciences. , The MSc in ... aims to equip cardiovascular specialists with the health ... take on advisory, management or leadership roles within ...
(Date:7/24/2014)... Texas at Arlington professor who co-authored a book ... in community revitalization has been awarded the Community ... Martinez-Cosio, associate professor in the School of Urban ... week at the society,s national conference, along with ... academic coordinator in the Urban Studies and Planning ...
(Date:7/24/2014)... seldom sufficient to read the declaration of contents if you ... fact, to do this you need to be a highly ... you can look directly into the molecular structure of the ... Engineering, is almost both, as he has developed a method ... biological samples. , The ,Fingerprints, of a Substance ...
Breaking Medicine News(10 mins):Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 2Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 3Health News:New Blood Test Advances Individualized Cancer Therapy and Cuts Down on Need for Painful Biopsies 2Health News:LSE and ESC announce the launch of a new executive-style MSc 2Health News:Strategy for community development partnerships earns award for UT Arlington professor 2Health News:Chemist develops X-ray vision for quality assurance 2Health News:Chemist develops X-ray vision for quality assurance 3
... of Emerging Models of Care , , ... The Case Management Society of America ( CMSA ) will host ... the Grand Hyatt San Antonio in San Antonio, Texas . ... Association of Social Workers, DMAA: The Care Continuum Alliance, and The ...
... retail opportunities for fresh roasted fortified coffee. , ... ... first in caffeine and fat burning fresh roasted coffee products, has ... partnership in the coffee industry will push the JavaFit brand ...
... Individuals reporting a history of periodontal disease were ... a risk factor for heart disease, compared to ... according to an American Journal of Cardiology ... from Columbia University Medical Center and NewYork-Presbyterian Hospital, ...
... L. Chao today announced the appointment of five members to ... (NACOSH). The committee, established under the Occupational Safety and ... health and human services on occupational safety and health programs. ... the advisory committee members, willingness to contribute their time and ...
... The Lose For Good(TM) Campaign Reaches $1 Million Dollar Donation ... Banks in Need , , ... WTW ) is pleased to announce the donation of one ... Strength and Action Against Hunger. The donation was made ...
... Inc. (Nasdaq: ALXN ) today announced that Dr. ... at the 20th Annual Piper Jaffray Health Care Conference in ... 2, 2008. , , An ... You can access the webcast at: www.alexionpharm.com . An ...
Cached Medicine News:Health News:2009 Collaborative Practice Summit to Bring Together Health Care Leaders 2Health News:2009 Collaborative Practice Summit to Bring Together Health Care Leaders 3Health News:JavaFit, Distributors of Vitamin Infused Fresh Roasted Coffee, Announces Partnership With CLR Roasters 2Health News:Presence of gum disease may help dentists and physicians identify risk for cardiovascular disease 2Health News:Presence of gum disease may help dentists and physicians identify risk for cardiovascular disease 3Health News:U.S. Labor Secretary Elaine L. Chao announces new membership of OSHA advisory committee 2Health News:U.S. Labor Secretary Elaine L. Chao announces new membership of OSHA advisory committee 3Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 2Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 3Health News:Weight Watchers Members and Online Subscribers Lose an Estimated 4 Million Pounds in Six Week Period 4
(Date:7/24/2014)... Lpath, Inc. (NASDAQ: LPTN ... reported interim results in a Phase 2a single-arm, ... a treatment for metastatic renal cell carcinoma (RCC) ... therapy involving a VEGF inhibitor (e.g., Sutent®/ sunitinib ... (e.g., Afinitor®/everolimus), with a maximum of three failed ...
(Date:7/24/2014)... 2014  Market Diagnostics International LLC ("MDxI") today ... , a data resource that sets a new ... and identifying target In Vitro Diagnostics (IVD) customers. ... provides IVD manufacturers with accurate and comprehensive information ... and consistent definitions of laboratory categories and institutional ...
(Date:7/24/2014)... , July 24, 2014   Cypher ... today a co-promotion agreement with Illumina to facilitate ... sequence data for precision medicine and clinical trials. ... companies, through Illumina,s sales force, a solution including ... for data analytics and storage, and Cypher Genomics, ...
Breaking Medicine Technology:Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 3
... IRVINE, Calif., June 12 Masimo (Nasdaq: ... Motion and Low-Perfusion pulse oximetry, announced today that three ... of Masimo PVI as a noninvasive and continuous measure ... week at the European Society of Anaesthesiology (ESA) Annual ...
... Safety and Biologic Activity Data Reviewed in End of Phase ... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... treatment of cardiovascular and metabolic disease, announced today that an ... VIA-2291 (atreleuton), was recently held with the U.S. Food and ...
Cached Medicine Technology:New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 2New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 3New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 4New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 5New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring 6VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: